Clinical Trials Directory

Trials / Completed

CompletedNCT01883674

Milk and Milk-produce to Counteract the Loss of Muscle Mass and Function in Exercising Older Adults.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
41 (actual)
Sponsor
Université de Sherbrooke · Academic / Other
Sex
Male
Age
65 Years – 75 Years
Healthy volunteers
Accepted

Summary

This project evaluates the use of different types of proteins from various food sources after an exercise session, on muscle mass and physical capacity in aged sarcopenic men (who have low muscle mass). Specifically, researchers want to: * Examine the efficiency of protein intake after exercise on muscle mass and physical abilities; * Examine the impact of exercise and proteins on blood lipids (LDL cholesterol, HDL cholesterol, total cholesterol and triglycerides); * Examine the impact of exercise and proteins on liver enzymes; * Examine the impact of exercise and proteins on a hormone that controls hunger; * Evaluate the program's impact on the ability of the body to produce energy. All participants are exercising (resistance training) and ingest one of the 3 different sources of proteins, immediately after training: * Milk proteins (from milk beverage) * Essential amino acids (added to a soya beverage) * No protein (rice beverage - control group) Our hypothesis is that proteins from milk will induce a gain in muscle mass and physical function equivalent to the essential amino acids (EAA). We anticipate that both milk proteins and EAA will be both superior to control group. This would represent an interesting finding since milk is more accessible, palatable and cheaper than essential amino acids commercial mix.

Conditions

Interventions

TypeNameDescription
OTHERResistance trainingAll group will exercise 3x/week. Each session of resistance training will last 60min. and will target main muscular groups.

Timeline

Start date
2012-05-01
Primary completion
2014-04-01
Completion
2014-12-01
First posted
2013-06-21
Last updated
2014-12-03

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01883674. Inclusion in this directory is not an endorsement.